As CD40-driven ICAM-1 expression and CCL2 production are essential for the pathogenesis of inflammatory diseases, including diabetic retinopathy, advanced glycation end products-mediated CD40 dysregulation is functionally relevant [40]. This evidence concerns the gene CD40 and diabetic retinopathy.